DF/HCC Calendar
|
|||||||||||||||||||||||
|
HSCI Stem Cell Symposium
Friday, November 6, 2009
Harvard Club of Boston
Click here for the event's website and link to registration (includes a scientific poster session)
November 6‑8, 2009
Dana‑Farber Cancer Institute, Boston, Massachusetts
Offered by: Dana‑Farber Cancer Institute
Course Director: Kenneth D. Miller, MD
Co‑Directors Larissa Nekhlyudov, MD, MPH and Richard Boyajian, NP
Call for Abstracts - due October 5 to Kaitlin_Ostrander@DFCI.HARVARD.EDU
Early Registration ends October 15
| NOVEMBER 6, 2009 | |
|---|---|
| MORNING SESSION: THE EMOTIONAL JOURNEY OF SURVIVORSHIP Moderator: Kenneth D. Miller, MD | |
| 8:30 | Opening Remarks Kenneth D. Miller, MD |
| 8:45 | Seasons of Survivorship Kenneth D. Miller, MD |
| 9:15 | The Emotional Journey of Survivorship‑An Overview Harriet K. Berman, PhD |
| 9:455 | Fear of Recurrence Amy Grose, LICSW |
| 10:15 | Coffee Break |
| 10:30 | Children of Cancer Survivors Vaughn Mankey, MD |
| 11:00 | “We’re in this Together” Co‑Survivors: Spouses and Partners of Cancer Survivors Jane Bausch, LICSW |
| 11:30 | Panel Discussion: The Emotional Journey of Survivorship Amy Grose, LICSW |
| 12:00 | Q&A Session |
| 12:30 | Lunch ‑ On your own |
| AFTERNOON SESSION: CAN WE REDUCE THE RISK OF SECOND CANCERS? Moderator: Julie Silver, MD | |
| 1:30 | Exercise and Cancer Jennifer Ligibel, MD |
| 2:00 | Fighting Cancer with a Fork: Nutrition and Cancer Jeffrey Meyerhardt, MD, MPH |
| 2:30 | Smoking and Smoking Cessation Elyse Park, PhD, MPH |
| 3:00 | Coffee Break |
| 3:15 | Second and Secondary Cancers Andrea Ng, MD, MPH |
| 3:45 | Cancer Rehabilitation Julie Silver, MD |
| 4:15 | Panel Discussion: Lifestyle in Cancer Survivorship Julie Silver, MD |
| 4:45 | Q&A Session |
| 5:00 | Dinner ‑ On your own / Optional Poster Session |
| EVENING SESSION: PRIMARY CARE SYMPOSIUM Moderator: Larissa Nekhlyudov, MD, MPH | |
| 6:30 | Who Will Care for Cancer Survivors? Lawrence N. Shulman, MD |
| 7:15 | What Is Optimal Care for Cancer Survivors: Primary Care, Oncologists, or Both? Larissa Nekhlyudov, MD, MPH |
| 7:45 | The Nuts and Bolts Approach to Survivorship Care: Richard Boyajian, NP Risk Assessment and Care Planning Karen Sommer, NP Psychosocial Counseling Amy Grose, LICSW Nutrition Counseling Stephanie Meyers, MS, RD, LDN |
| 9:00 | Q&A Session |
| NOVEMBER 7, 2009 | |
| MORNING SESSION: CANCER SURVIVORSHIP FOR WOMEN Moderator: Ann Partridge, MD, MPH | |
| 8:30 | Sexuality and Intimacy Jennifer Potter, MD |
| 9:00 | Endocrine Issues,Menopause, and Bone Health Jean Mulder, MD |
| 9:30 | Screening after Cancer ‑ Compliance Concerns Susan E. Pories, MD, FACS |
| 10:00 | Q&A Session |
| 10:15 | Coffee Break |
| 10:30 | Gynecologic Issues Sandy Falk, MD |
| 11:00 | Special Survivorship Concerns for Women with Breast Cancer Ann Partridge, MD, MPH |
| 11:30 | Panel Discussion: Women and Survivorship Ann Partridge, MD, MPH |
| 12:00 | Q&A Session |
| 12:15 | Lunch ‑ On your own |
| AFTERNOON SESSION: KEEPING CANCER SURVIVORS HEALTHY Moderator: Lawrence N. Shulman, MD | |
| 1:15 | Medical Issues for Adult Survivors of Childhood Cancer Lisa Diller, MD |
| 1:45 | Pulmonary Issues for Cancer Survivors Gerald Weinhouse, MD |
| 2:15 | Renal Issues after Cancer Therapy Benjamin D. Humphreys, MD, PhD |
| 2:45 | Q&A Session |
| 3:00 | Coffee Break |
| 3:15 | Cardiac Issues for Cancer Survivors Javid Moslehi, MD |
| 3:45 | Oral Health Issues Nathaniel S. Treister, DMD, DMSc |
| 4:15 | Panel Discussion: Keeping Cancer Survivors Healthy Lawrence N. Shulman, MD |
| 4:45 | Q&A Session |
| NOVEMBER 8, 2009 | |
| MORNING SESSION: CANCER SURVIVORSHIP FOR MEN Moderator: Kenneth D. Miller, MD | |
| 8:30 | Sexual Health for Men after Cancer William Conners, MD |
| 9:00 | Depression and Anxiety in Men after Cancer Frank McCaffrey, LICSW, OSW‑C |
| 9:30 | A Panel of Men Who Are Cancer Survivors Frank McCaffrey, LICSW, OSW‑C |
| 10:00 | Q&A Session |
| 10:15 | Coffee Break |
| MINI‑SEMINAR: MEDICAL ISSUES IN SURVIVORSHIP: MORE ON KEEPING CANCER SURVIVORS HEALTHY Moderator: Kenneth D. Miller, MD | |
| 10:30 | Cognitive Problems “Chemobrain” Mary‑Ellen Meadows, PhD |
| 11:00 | Neurologic Problems Patrick Wen, MD |
| 11:30 | Dermatologic Problems Arturo Saavedra, MD, PhD, MBA |
| 12:00 | Pain and Symptom Management in Cancer Survivors Jane deLima Thomas, MD |
| 12:30 | Q&A Session |
| 1:00 | Lunch ‑ On your own |
| AFTERNOON SESSION: ONCOFERTILITY SEMINAR Moderator: Karen Fasciano, PsyD | |
| 2:00 | Fertility for Women after Cancer Elizabeth Ginsburg, MD |
| 2:30 | Fertility for Men after Cancer Kevin Loughlin, MD |
| 3:00 | The Emotional Side of Infertility after Cancer Karen Fasciano, PsyD |
| 3:30 | Q&A Session |
| 4:00 | Closing Remarks Kenneth D. Miller, MD |
Friday, November 6, 2009
10:30 am - 11:30 am
Pathology Conference Room
Brigham and Women's Hospital
Amory 3
CONFERENCE TITLE: Improved Adoptive Immunotherapy for EGFRvIII expressing glioblastoma through '3rd generation' chimeric receptor engineered T cells
Ayguen Sahin, PhD
Instructor at Harvard Medical School
MGH-HMS Center for Nervous System Repair
Department of Neurosurgery
Biomarkers and Genetic Alterations in Systemic Cancers and Brain Tumors
On behalf of the organizers, we would like to invite you to attend the 9th Frye Halloran Symposium at Massachusetts General Hospital. On November 5-6, 2009, a team of international experts will address the issue of novel assays of molecular targets in patients with systemic malignancies and brain tumors. We invite you to attend this tuition-free meeting.
Speakers will address molecular targets of cancers of lung, breast and gastrointestinal origin as well as glioblastoma. Emphasis will be placed on common themes such as EGF amplification that appears in lung cancer and brain tumors; the evaluation of chromosomal and protein alterations in tumor patients, and the role of circulating tumor cells. A focus of the meeting will be the discussion of the novel identification of circulating DNA and RNA molecular targets both in glioma and systemic cancers. Clearly the hope is to rapidly advance these technologies by incorporating them into clinical trials of molecularly targeted agents.
The Symposium will be of interest to Medical Oncologists, Clinical Neuro-Oncologists, specialists in studies of ‘designer’ drugs, scientists working in molecular pathways as well as molecular epidemiologists, clinical trialists and pathologists.
We ask that you explore our Website http://fh2009.neurosuite.org for more information. If you wish to attend this free symposium please register on the website or contact Rita Gould at (617) 726-8657 or rgould2@partners.org.
Dana-Farber/Harvard Cancer Center
A Comprehensive Cancer CenterDesignated by the National Cancer Institute